Company: FTII
Filing Date: 2025-08-18
Form Type: 8-K
Source: 0001641172-25-024668
Chunk: 3

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-18
Form: 8-K
Item: Item 1.01
Chunk 3
---
 and infrastructure of Longevity as a result of
the announcement and consummation of the Business Combination; risks that Longevity is unable to secure or protect its intellectual property;
risks that the combined company experiences difficulties managing its growth and expanding operations; the ability to compete with existing
or new companies that could slow the development of Longevity’s products or cause downward pressure on prices, fewer customer orders,
reduced margins, the inability to take advantage of new business opportunities, and the loss of market share; the amount of redemption
requests made by the Company’s shareholders; the impact of the COVID-19 pandemic; the ability to successfully select, execute or
integrate future acquisitions into the business, which could result in material adverse effects to operations and financial conditions;
and those factors discussed in the sections entitled “ RiskFactors” and “ Special Note Regarding Forward-Looking
Statements” in the Company’s Special Report on Form 10-K for the rear ended December 31, 2024 and the Quarterly Report on
Form 10-Q for the quarter ended March 31, 2024, and in those documents that the Company has filed, or will file, with the U. S. Securities
and Exchange Commission (the “ SEC

   3  

Important
Information for Investors and Stockholders

The
Business Combination will be submitted to shareholders of the Company for their consideration and approval at a special meeting of shareholders.
The Company and Longevity have prepared a Registration Statement that has been filed with the SEC by the Company, which includes a preliminary
and definitive proxy statements to be distributed to the Company’s shareholders in connection with the Company’s solicitation
for proxies for the vote by the Company’s shareholders in connection with the Business Combination and other matters as described
in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to the Company’s
shareholders and certain of the Company’s equity holders in connection with the completion of the Business Combination. After the
Registration Statement has been filed and declared effective, the Company will mail a definitive proxy statement and other relevant documents
to its shareholders as of the record date established for voting on the Business Combination. The Company’s stockholders and
other interested persons are advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and,
once available, the definitive proxy statement/prospectus, in connection with the Company’s solicitation of proxies for its special
meeting of stockholders to be held to approve,